When thalidomide came to market in the 1950s as a morning sickness treatment, no one imagined the many cases of birth defects that would result from use of the drug. More than 50 years later, a small Madison-based stem cell company is selling a research product that could have prevented what some have called one of the biggest medical tragedies of modern times. Read full Journal Sentinel story here.
- Browsing WARF, WiSys portfolios for industry topic of Dec. 13 Tech Council luncheon in AppletonNovember 20, 2018
- WisBusiness: GrowthChart could be the teacher’s new best friendNovember 20, 2018
- It’s a wrap: Early Stage Symposium 2018!November 19, 2018
- InsideWis: Colorado’s state brand has some deep Badger rootsNovember 15, 2018
- Wisconsin State Journal: Blexx, a startup whose tool destroys used hypodermic needles, wins Madison pitch contest.November 9, 2018